Search Results - "Kristoffer Haugarvoll"

Refine Results
  1. 1

    A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population by Brakedal, Brage, Toker, Lilah, Haugarvoll, Kristoffer, Tzoulis, Charalampos

    Published in NPJ Parkinson's Disease (02-03-2022)
    “…Epidemiological studies of Parkinson’s disease (PD) show variable and partially conflicting findings with regard to incidence, prevalence, and mortality. These…”
    Get full text
    Journal Article
  2. 2

    Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease by Dölle, Christian, Flønes, Irene, Nido, Gonzalo S., Miletic, Hrvoje, Osuagwu, Nelson, Kristoffersen, Stine, Lilleng, Peer K., Larsen, Jan Petter, Tysnes, Ole-Bjørn, Haugarvoll, Kristoffer, Bindoff, Laurence A., Tzoulis, Charalampos

    Published in Nature communications (22-11-2016)
    “…Increased somatic mitochondrial DNA (mtDNA) mutagenesis causes premature aging in mice, and mtDNA damage accumulates in the human brain with aging and…”
    Get full text
    Journal Article
  3. 3

    NSAID use is not associated with Parkinson’s disease incidence: A Norwegian Prescription Database study by Brakedal, Brage, Tzoulis, Charalampos, Tysnes, Ole-Bjørn, Haugarvoll, Kristoffer

    Published in PloS one (07-09-2021)
    “…Objective Whether use of nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the risk of incident Parkinson’s disease (PD) remains unresolved. Here, we…”
    Get full text
    Journal Article
  4. 4

    Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain by Toker, Lilah, Tran, Gia T, Sundaresan, Janani, Tysnes, Ole-Bjørn, Alves, Guido, Haugarvoll, Kristoffer, Nido, Gonzalo S, Dölle, Christian, Tzoulis, Charalampos

    Published in Molecular neurodegeneration (05-05-2021)
    “…Parkinson's disease (PD) is a complex, age-related neurodegenerative disorder of largely unknown etiology. PD is strongly associated with mitochondrial…”
    Get full text
    Journal Article
  5. 5

    NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease by Berven, Haakon, Kverneng, Simon, Sheard, Erika, Søgnen, Mona, Af Geijerstam, Solveig Amdahl, Haugarvoll, Kristoffer, Skeie, Geir-Olve, Dölle, Christian, Tzoulis, Charalampos

    Published in Nature communications (28-11-2023)
    “…Nicotinamide adenine dinucleotide (NAD) replenishment therapy using nicotinamide riboside (NR) shows promise for Parkinson’s disease (PD) and other…”
    Get full text
    Journal Article
  6. 6

    Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci by Gaare, Johannes Jernqvist, Nido, Gonzalo, Dolle, Christian, Sztromwasser, Pawel, Alves, Guido, Tysnes, Ole-Bjorn, Haugarvoll, Kristoffer, Tzoulis, Charalampos

    Published in PloS one (01-10-2020)
    “…Parkinson disease (PD) is a complex neurodegenerative disorder influenced by both environmental and genetic factors. While genome wide association studies have…”
    Get full text
    Journal Article
  7. 7

    Common gene expression signatures in Parkinson's disease are driven by changes in cell composition by Nido, Gonzalo S, Dick, Fiona, Toker, Lilah, Petersen, Kjell, Alves, Guido, Tysnes, Ole-Bjørn, Jonassen, Inge, Haugarvoll, Kristoffer, Tzoulis, Charalampos

    Published in Acta neuropathologica communications (21-04-2020)
    “…The etiology of Parkinson's disease is largely unknown. Genome-wide transcriptomic studies in bulk brain tissue have identified several molecular signatures…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy by Flønes, Irene, Sztromwasser, Paweł, Haugarvoll, Kristoffer, Dölle, Christian, Lykouri, Maria, Schwarzlmüller, Thomas, Jonassen, Inge, Miletic, Hrvoje, Johansson, Stefan, Knappskog, Per M, Bindoff, Laurence A, Tzoulis, Charalampos

    Published in PloS one (10-02-2016)
    “…Biotin-thiamine responsive basal ganglia disease is a severe, but potentially treatable disorder caused by mutations in the SLC19A3 gene. Although the disease…”
    Get full text
    Journal Article
  11. 11

    GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies by Haugarvoll, Kristoffer, Johansson, Stefan, Rodriguez, Carlos E, Boman, Helge, Haukanes, Bjørn Ivar, Bruland, Ove, Roque, Francisco, Jonassen, Inge, Blomqvist, Maria, Telstad, Wenche, Månsson, Jan-Eric, Knappskog, Per Morten, Bindoff, Laurence A

    Published in PloS one (2017)
    “…With the advent new sequencing technologies, we now have the tools to understand the phenotypic diversity and the common occurrence of phenocopies. We used…”
    Get full text
    Journal Article
  12. 12

    Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson’s disease by Gaare, Johannes J., Dölle, Christian, Brakedal, Brage, Brügger, Kim, Haugarvoll, Kristoffer, Nido, Gonzalo S., Tzoulis, Charalampos

    Published in iScience (17-03-2023)
    “…Replenishing nicotinamide adenine dinucleotide (NAD) via supplementation of nicotinamide riboside (NR) has been shown to confer neuroprotective effects in…”
    Get full text
    Journal Article
  13. 13

    Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia by Farrer, Matthew J, Stone, Jeremy T, Lin, Chin-Hsien, Dächsel, Justus C, Hulihan, Mary M, Haugarvoll, Kristoffer, Ross, Owen A, Wu, Ruey-Meei

    Published in Parkinsonism & related disorders (01-03-2007)
    “…Abstract The goal of genetic association studies is to identify common (>5%) risk factors in complex disease traits. Herein we describe the first replicable…”
    Get full text
    Journal Article
  14. 14
  15. 15

    MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing by Haugarvoll, Kristoffer, Johansson, Stefan, Tzoulis, Charalampos, Haukanes, Bjørn Ivar, Bredrup, Cecilie, Neckelmann, Gesche, Boman, Helge, Knappskog, Per Morten, Bindoff, Laurence A

    Published in Orphanet journal of rare diseases (03-01-2013)
    “…Correct diagnosis is pivotal to understand and treat neurological disease. Herein, we report the diagnostic work-up utilizing exome sequencing and the…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    ELAVL4, PARK10, and the Celts by Haugarvoll, Kristoffer, Toft, Mathias, Ross, Owen A., Stone, Jeremy T., Heckman, Michael G., White, Linda R., Lynch, Timothy, Gibson, John Mark, Wszolek, Zbigniew K., Uitti, Ryan J., Aasly, Jan O., Farrer, Matthew J.

    Published in Movement disorders (15-03-2007)
    “…Genetic variability in ELAVL4 located in the PARK10 locus was recently associated with age‐at‐onset (AAO) in a series of Parkinson's disease (PD) patients…”
    Get full text
    Journal Article
  20. 20

    The Genetics of Frontotemporal Dementia by Haugarvoll, Kristoffer, MD, Wszolek, Zbigniew K., MD, Hutton, Michael, PhD

    Published in Neurologic clinics (01-08-2007)
    “…This article describes the remarkable progress that has been made over the past decade in identifying the genetic contribution to frontotemporal dementia. The…”
    Get full text
    Journal Article